Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Sarcopenia is a geriatric syndrome with a significant impact on older patients’ quality of life, morbidity and mortality. Despite the new available criteria, its early diagnosis remains difficult, highlighting the necessity of looking for a valid muscle wasting biomarker. Myostatin, a muscle mass negative regulator, is one of the potential candidates. The aim of this work is to point out various factors affecting the potential of myostatin as a biomarker of muscle wasting. Based on the literature review, we can say that recent studies produced conflicting results and revealed a number of potential confounding factors influencing their use in sarcopenia diagnosing. These factors include physiological variables (such as age, sex and physical activity) as well as a variety of disorders (including heart failure, metabolic syndrome, kidney failure and inflammatory diseases) and differences in laboratory measurement methodology. Our conclusion is that although myostatin alone might not prove to be a feasible biomarker, it could become an important part of a recently proposed panel of muscle wasting biomarkers. However, a thorough understanding of the interrelationship of these markers, as well as establishing a valid measurement methodology for myostatin and revising current research data in the light of new criteria of sarcopenia, is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 1×
“The pathogenesis of this disorder comprises of various factors and mechanisms [7,8], including genetic variability [9,10], cytokine activity [11–13], vitamin D, testosterone and growth hormone deficiency [14–17], mitochondrial dysfunction and apoptosis [18–20], muscle disuse [15,21,22], nutritional status [23,24], ath…”
BackgroundRegulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 1×
“The pathogenesis of this disorder comprises of various factors and mechanisms [7,8], including genetic variability [9,10], cytokine activity [11–13], vitamin D, testosterone and growth hormone deficiency [14–17], mitochondrial dysfunction and apoptosis [18–20], muscle disuse [15,21,22], nutritional status [23,24], ath…”
BackgroundRegulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Clop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Undulating changes in human plasma proteome profiles across the lifespan
Lehallier, B., Gate, D., Schaum, N., Nanasi, T., Lee, S. E., Yousef, H., Moran Losada, P., Berdnik, D., Keller, A., Verghese, J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0673-2 · Cited by 981 · cited 2×
“The second one was an analysis of samples collected in two large cohort studies, and it found a decrease of serum myostatin with age in the general population, with a trend for an increase in the female population and a decrease in male patients when analyzed separately [110].”
MethodResultLoffredo, F. S., Steinhauser, M. L., Jay, S. M., Gannon, J., Pancoast, J. R., Yalamanchi, P., Sinha, M., Dall’Osso, C., Khong, D., Shadrach, J. L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.015 · Cited by 948
Mosher, D. S., Quignon, P., Bustamante, C. D., Sutter, N. B., Mellersh, C. S., Parker, H. G., & Ostrander, E. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030079 · Cited by 826
Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle
Sinha, M., Jang, Y. C., Oh, J., Khong, D., Wu, E. Y., Manohar, R., Miller, C., Regalado, S. G., Loffredo, F. S., Pancoast, J. R., et al. (2014) · Science · doi:10.1126/science.1251152 · Cited by 824
Predictors of skeletal muscle mass in elderly men and women
Baumgartner, R. N., Waters, D. L., Gallagher, D., Morley, J. E., & Garry, P. J. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00130-4 · Cited by 809 · cited 1×
“The pathogenesis of this disorder comprises of various factors and mechanisms [7,8], including genetic variability [9,10], cytokine activity [11–13], vitamin D, testosterone and growth hormone deficiency [14–17], mitochondrial dysfunction and apoptosis [18–20], muscle disuse [15,21,22], nutritional status [23,24], ath…”
BackgroundExcessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Lee, J. S., Kuller, L. H., Boudreau, R., de Rekeneire, N., Harris, T. B., Kritchevsky, S., Tylavsky, F. A., Nevitt, M., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0264 · Cited by 778 · cited 1×
“The pathogenesis of this disorder comprises of various factors and mechanisms [7,8], including genetic variability [9,10], cytokine activity [11–13], vitamin D, testosterone and growth hormone deficiency [14–17], mitochondrial dysfunction and apoptosis [18–20], muscle disuse [15,21,22], nutritional status [23,24], ath…”
BackgroundDecreased Muscle Strength and Quality in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., & Newman, A. B. (2006) · Diabetes · doi:10.2337/db05-1183 · Cited by 751 · cited 1×
“The pathogenesis of this disorder comprises of various factors and mechanisms [7,8], including genetic variability [9,10], cytokine activity [11–13], vitamin D, testosterone and growth hormone deficiency [14–17], mitochondrial dysfunction and apoptosis [18–20], muscle disuse [15,21,22], nutritional status [23,24], ath…”
BackgroundFerrucci, L., Penninx, B. W. J. H., Volpato, S., Harris, T. B., Bandeen‐Roche, K., Balfour, J., Leveille, S. G., Fried, L. P., & Md, J. M. G. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50605.x · Cited by 618
GDF11 increases with age and inhibits skeletal muscle regeneration
Egerman, M. A., Cadena, S. M., Gilbert, J. A., Meyer, A., Nelson, H. N., Swalley, S. E., Mallozzi, C., Jacobi, C., Jennings, L. L., Clay, I., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.010 · Cited by 527
Suppression of body fat accumulation in myostatin-deficient mice
McPherron, A. C., & Lee, S.-J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213562 · Cited by 505 · cited 1×
“Myostatin is most abundant in skeletal muscle; however, its expression was noted in cardiac muscle and in adipose tissue [51,52].”
BackgroundMayhew, A. J., Amog, K., Phillips, S., Parise, G., McNicholas, P. D., de Souza, R. J., Thabane, L., & Raina, P. (2019) · Age and Ageing · doi:10.1093/ageing/afy106 · Cited by 478 · cited 1×
“9%) among community-dwelling older adults [2].”
Mitochondrial function and apoptotic susceptibility in aging skeletal muscle
Chabi, B., Ljubicic, V., Menzies, K. J., Huang, J. H., Saleem, A., & Hood, D. A. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00347.x · Cited by 437
Sarcopenia as the biological substrate of physical frailty
Landi, F., Calvani, R., Cesari, M., Tosato, M., Martone, A. M., Bernabei, R., Onder, G., & Marzetti, E. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.04.005 · Cited by 288 · cited 1×
“Furthermore, sarcopenia remains intertwined and overlapping with other syndromes such as frailty [31,32] and cachexia [33,34], and its development significantly worsens the prognosis of various diseases such as heart failure [35,36], chronic kidney disease [37] and liver failure [38].”
BackgroundPhillips, T., & Leeuwenburgh, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2870fje · Cited by 283
Regulation of Muscle Mass by Follistatin and Activins
Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0127 · Cited by 273 · cited 1×
“Follistatin, a single-chain glycosylated protein, is expressed in various tissues and antagonizes both myostatin and activin A activity, influencing their effects on muscle mass [115,116].”
BackgroundGilson, H., Schakman, O., Kalista, S., Lause, P., Tsuchida, K., & Thissen, J.-P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00193.2009 · Cited by 248
Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
Heineke, J., Auger-Messier, M., Xu, J., Sargent, M., York, A., Welle, S., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.109.882068 · Cited by 238 · cited 1×
“Despite early studies on myostatin indicating an increase of its serum concentration in heart failure (HF) [164,165], research by Furihata et al.”
BackgroundSchaap, L. A., Pluijm, S. M. F., Smit, J. H., Van Schoor, N. M., Visser, M., Gooren, L. J. G., & Lips, P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02315.x · Cited by 168
Whitman, S. A., Wacker, M. J., Richmond, S. R., & Godard, M. P. (2005) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-1473-8 · Cited by 156
Bergen, H. R., Farr, J. N., Vanderboom, P. M., Atkinson, E. J., White, T. A., Singh, R. J., Khosla, S., & LeBrasseur, N. K. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0047-5 · Cited by 137
Mcdermott, M. M., Guralnik, J. M., Albay, M., Bandinelli, S., Miniati, B., & Ferrucci, L. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52113.x · Cited by 119
Cellular and molecular mechanisms of sarcopenia: The S100B perspective
Riuzzi, F., Sorci, G., Arcuri, C., Giambanco, I., Bellezza, I., Minelli, A., & Donato, R. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12363 · Cited by 114 · cited 1×
“sarcopenia, the result of chronic inflammatory statuses, diabetes, hormonal alterations, vascular disturbances, renal, respiratory and/or cardiac failure and immobilization [29,30].”
BackgroundPeng, L., Lee, W., Liu, L., Lin, M., & Chen, L. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12302 · Cited by 93 · cited 2×
“It would be reasonable to adopt the approach used by many researchers who, in order to produce reliable results and circumvent the impact of serum myostatin changes with various parameters, adjusted myostatin concentration for total body lean mass (which could clarify prior, contradictory results) [85,120], age [120],…”
BackgroundMethodSerum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans
Amor, M., Itariu, B. K., Moreno-Viedma, V., Keindl, M., Jürets, A., Prager, G., Langer, F., Grablowitz, V., Zeyda, M., & Stulnig, T. M. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0641-5546 · Cited by 93 · cited 2×
“Other studies confirmed the association of serum myostatin with dysglycemia; the circulating myostatin concentration was found to be higher in prediabetes and the highest in type 2 diabetes mellitus in comparison with healthy controls [150], and it was correlated with fasting plasma glucose, HOMA-IR (Homeostatic Model…”
BackgroundResultHjorth, M., Pourteymour, S., Görgens, S. W., Langleite, T. M., Lee, S., Holen, T., Gulseth, H. L., Birkeland, K. I., Jensen, J., Drevon, C. A., et al. (2016) · Acta Physiologica · doi:10.1111/apha.12631 · Cited by 83
Bagheri, R., Moghadam, B. H., Church, D. D., Tinsley, G. M., Eskandari, M., Moghadam, B. H., Motevalli, M. S., Baker, J. S., Robergs, R. A., & Wong, A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110869 · Cited by 81
Pugh, J. K., Faulkner, S. H., Jackson, A. P., King, J. A., & Nimmo, M. A. (2015) · Physiological Reports · doi:10.14814/phy2.12364 · Cited by 63
Myokine/Adipokine response to “Aerobic” exercise: Is it just a matter of exercise load?
He, Z., Tian, Y., Valenzuela, P. L., Huang, C., Zhao, J., Hong, P., He, Z., Yin, S., & Lucia, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00691 · Cited by 59
Parker, L., Caldow, M. K., Watts, R., Levinger, P., Cameron-Smith, D., & Levinger, I. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3639-4 · Cited by 36
Popov, D. V., Lysenko, E. A., Bachinin, A. V., Miller, T. F., Kurochkina, N. S., Kravchenko, I. V., Furalyov, V. A., & Vinogradova, O. L. (2015) · Muscle & Nerve · doi:10.1002/mus.24314 · Cited by 32
Sousa-Santos, A. R., Afonso, C., Borges, N., Santos, A., Padrão, P., Moreira, P., & F Amaral, T. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033661 · Cited by 27
Targeted Approach to Distinguish and Determine Absolute Levels of GDF8 and GDF11 in Mouse Serum
Camparini, L., Kollipara, L., Sinagra, G., Loffredo, F. S., Sickmann, A., & Shevchuk, O. (2020) · PROTEOMICS · doi:10.1002/pmic.201900104 · Cited by 8
Research works printed but not linked: 155
- Uemura, 2019, Sarcopenia and Low Serum Albumin Level Synergistically Increase the Risk of Incident Disability in Older Adults, J. Am. Med. Dir. Assoc., 20, 90, 10.1016/j.jamda.2018.06.011 · DOI
- Beaudart, 2015, Quality of life and physical components linked to sarcopenia: The SarcoPhAge study, Exp. Gerontol., 69, 103, 10.1016/j.exger.2015.05.003 · DOI · Paper page
- Arroyo, 2013, Mortality as an adverse outcome of sarcopenia, J. Nutr. Health Aging, 17, 259, 10.1007/s12603-012-0434-0 · DOI · Paper page
- Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.Y., and Bruyere, O. (2017). Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS ONE, 12. · DOI · Paper page
- Welle, 2003, Gene expression profile of aging in human muscle, Physiol. Genom., 14, 149, 10.1152/physiolgenomics.00049.2003 · DOI · Paper page
- Schrager, 2004, Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span, J. Appl. Physiol. (1985), 97, 2176, 10.1152/japplphysiol.00985.2003 · DOI · Paper page
- Rong, Y.D., Bian, A.L., Hu, H.Y., Ma, Y., and Zhou, X.Z. (2018). Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr., 18. · DOI · Paper page
- Visser, 2003, Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam, J. Clin. Endocrinol. Metab., 88, 5766, 10.1210/jc.2003-030604 · DOI · Paper page
- Bian, A., Ma, Y., Zhou, X., Guo, Y., Wang, W., Zhang, Y., and Wang, X. (2020). Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet. Disord., 21. · DOI · Paper page
- Hiona, A., Sanz, A., Kujoth, G.C., Pamplona, R., Seo, A.Y., Hofer, T., Someya, S., Miyakawa, T., Nakayama, C., and Samhan-Arias, A.K. (2010). Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS ONE, 5. · DOI · Paper page
- Kuh, 2005, Grip strength, postural control, and functional leg power in a representative cohort of British men and women: Associations with physical activity, health status, and socioeconomic conditions, J. Gerontol. A Biol. Sci. Med. Sci., 60, 224, 10.1093/gerona/60.2.224 · DOI · Paper page
- Kortebein, 2008, Functional impact of 10 days of bed rest in healthy older adults, J. Gerontol. A Biol. Sci. Med. Sci., 63, 1076, 10.1093/gerona/63.10.1076 · DOI · Paper page
- Hai, 2017, Association between sarcopenia and nutritional status and physical activity among community-dwelling Chinese adults aged 60 years and older, Geriatr. Gerontol. Int., 17, 1959, 10.1111/ggi.13001 · DOI
- Bahat, 2010, Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey, Aging Male, 13, 211, 10.3109/13685538.2010.489130 · DOI · Paper page
- McDermott, 2001, Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment, JAMA, 286, 1599, 10.1001/jama.286.13.1599 · DOI · Paper page
- Morley, 2018, Treatment of sarcopenia: The road to the future, J. Cachexia Sarcopenia Muscle, 9, 1196, 10.1002/jcsm.12386 · DOI · Paper page
- Yaxley, 2012, The complexity of treating wasting in ambulatory rehabilitation: Is it starvation, sarcopenia, cachexia or a combination of these conditions?, Asia Pac. J. Clin. Nutr., 21, 386
- Gingrich, A., Volkert, D., Kiesswetter, E., Thomanek, M., Bach, S., Sieber, C.C., and Zopf, Y. (2019). Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatr., 19. · DOI · Paper page
- Narumi, 2015, Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure, Eur. J. Intern. Med., 26, 118, 10.1016/j.ejim.2015.01.008 · DOI
- Hu, 2018, Sarcopenia and long-term prognosis of patients with chronic heart failure in patients aged 70 years and over, Zhonghua Nei Ke Za Zhi, 57, 212
- Pereira, 2015, Sarcopenia in chronic kidney disease on conservative therapy: Prevalence and association with mortality, Nephrol. Dial. Transplant., 30, 1718, 10.1093/ndt/gfv133 · DOI · Paper page
- Mauro, 2020, Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List, Transplantation, 104, e188, 10.1097/TP.0000000000003222 · DOI
- Scherbakov, 2018, Cachexia as a common characteristic in multiple chronic disease, J. Cachexia Sarcopenia Muscle, 9, 1189, 10.1002/jcsm.12388 · DOI
- Bowen, 2015, Skeletal muscle wasting in cachexia and sarcopenia: Molecular pathophysiology and impact of exercise training, J. Cachexia Sarcopenia Muscle, 6, 197, 10.1002/jcsm.12043 · DOI · Paper page
- Argiles, 2006, Muscle wasting in cancer and ageing: Cachexia versus sarcopenia, Adv. Gerontol., 18, 39
- Douglas, 2014, Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score, Cancer Treat. Rev., 40, 685, 10.1016/j.ctrv.2013.11.007 · DOI
- Silva, 2020, Clinical utility of the modified Glasgow Prognostic Score to classify cachexia in patients with advanced cancer in palliative care, Clin. Nutr., 39, 1587, 10.1016/j.clnu.2019.07.002 · doi:10.1016/j.clnu.2019.07.002
- Califf, 2018, Biomarker definitions and their applications, Exp. Biol. Med. (Maywood), 243, 213, 10.1177/1535370217750088 · DOI · Paper page
- Calvani, 2015, Biomarkers for physical frailty and sarcopenia: State of the science and future developments, J. Cachexia Sarcopenia Muscle, 6, 278, 10.1002/jcsm.12051 · DOI · Paper page
- Sharma, 1999, Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct, J. Cell Physiol., 180, 1, 10.1002/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V · DOI · Paper page
- Thies, 2001, GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding, Growth Factors, 18, 251, 10.3109/08977190109029114 · DOI · Paper page
- Wolfman, 2003, Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases, Proc. Natl. Acad. Sci. USA, 100, 15842, 10.1073/pnas.2534946100 · DOI · Paper page
- Langley, 2002, Myostatin inhibits myoblast differentiation by down-regulating MyoD expression, J. Biol. Chem., 277, 49831, 10.1074/jbc.M204291200 · DOI · Paper page
- Rebbapragada, 2003, Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis, Mol. Cell Biol., 23, 7230, 10.1128/MCB.23.20.7230-7242.2003 · DOI · Paper page
- Hennebry, 2009, Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression, Am. J. Physiol. Cell Physiol., 296, C525, 10.1152/ajpcell.00259.2007 · DOI · Paper page
- Amirouche, 2009, Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle, Endocrinology, 150, 286, 10.1210/en.2008-0959 · DOI · Paper page
- Bonala, 2014, Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake, J. Biol. Chem., 289, 7654, 10.1074/jbc.M113.529925 · DOI
- Bonala, 2013, Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity, Mol. Endocrinol., 27, 1518, 10.1210/me.2013-1048 · DOI
- Ma, 2001, Characterization of 5’-regulatory region of human myostatin gene: Regulation by dexamethasone in vitro, Am. J. Physiol. Endocrinol. Metab., 281, E1128, 10.1152/ajpendo.2001.281.6.E1128 · DOI · Paper page
- Valdes, 2013, IGF-1 induces IP3 -dependent calcium signal involved in the regulation of myostatin gene expression mediated by NFAT during myoblast differentiation, J. Cell Physiol., 228, 1452, 10.1002/jcp.24298 · DOI · Paper page
- Lenk, 2009, Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model, Eur. J. Heart Fail., 11, 342, 10.1093/eurjhf/hfp020 · DOI · Paper page
- Wang, 2008, Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway, J. Endocrinol., 197, 85, 10.1677/JOE-07-0596 · DOI
- Carneiro, 2008, Hypothyroidism is associated with increased myostatin expression in rats, J. Endocrinol. Investig., 31, 773, 10.1007/BF03349256 · DOI
- Qiu, 2013, Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-kappaB-mediated mechanism, Proc. Natl. Acad. Sci. USA, 110, 18162, 10.1073/pnas.1317049110 · DOI · Paper page
- Drummond, 2009, Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle, J. Nutr., 139, 2279, 10.3945/jn.109.112797 · DOI
- Kim, 2007, Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: A cluster analysis, J. Appl. Physiol. (1985), 103, 1488, 10.1152/japplphysiol.01194.2006 · DOI · Paper page
- Li, 2019, Effect of Hypoxia on the Muscle Fiber Switching Signal Pathways CnA/NFATc1 and Myostatin in Mouse Myocytes, Acta Histochem., 121, 539, 10.1016/j.acthis.2019.04.001 · DOI
- Forbes, 2006, Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism, J. Cell. Physiol., 206, 264, 10.1002/jcp.20477 · DOI · Paper page
- Callis, 2009, MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice, J. Clin. Investig., 119, 2772, 10.1172/JCI36154 · DOI · Paper page
- Liu, 2007, An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133, Proc. Natl. Acad. Sci. USA, 104, 20844, 10.1073/pnas.0710558105 · DOI · Paper page
- Welle, 2002, Insulin-like growth factor-1 and myostatin mRNA expression in muscle: Comparison between 62–77 and 21–31 yr old men, Exp. Gerontol., 37, 833, 10.1016/S0531-5565(02)00025-6 · DOI
- Elliott, 2012, The central role of myostatin in skeletal muscle and whole body homeostasis, Acta Physiol. (Oxf.), 205, 324, 10.1111/j.1748-1716.2012.02423.x · DOI · Paper page
- Huang, 2011, Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation, Cell. Signal., 23, 1441, 10.1016/j.cellsig.2011.05.003 · DOI
- Dschietzig, 2014, Myostatin—From the Mighty Mouse to cardiovascular disease and cachexia, Clin. Chim. Acta, 433, 216, 10.1016/j.cca.2014.03.021 · DOI
- Yamada, 2016, Factors Associated with the Serum Myostatin Level in Patients Undergoing Peritoneal Dialysis: Potential Effects of Skeletal Muscle Mass and Vitamin D Receptor Activator Use, Calcif. Tissue Int., 99, 13, 10.1007/s00223-016-0118-6 · DOI
- Zhou, Y., Hellberg, M., Hellmark, T., Hoglund, P., and Clyne, N. (2019). Muscle mass and plasma myostatin after exercise training: A substudy of Renal Exercise (RENEXC)—A randomized controlled trial. Nephrol. Dial. Transplant. · DOI
- Loumaye, 2015, Role of Activin A and myostatin in human cancer cachexia, J. Clin. Endocrinol. Metab., 100, 2030, 10.1210/jc.2014-4318 · DOI · Paper page
- Comas, 2019, Circulating Irisin and Myostatin as Markers of Muscle Strength and Physical Condition in Elderly Subjects, Front. Physiol., 10, 871, 10.3389/fphys.2019.00871 · DOI · Paper page
- Furihata, 2016, Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure, Int. J. Cardiol., 220, 483, 10.1016/j.ijcard.2016.06.231 · DOI
- Delanaye, 2019, Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis, J. Ren. Nutr., 29, 511, 10.1053/j.jrn.2018.11.010 · DOI
- Moriwaki, K., Matsumoto, H., Tanishima, S., Tanimura, C., Osaki, M., Nagashima, H., and Hagino, H. (2019). Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: A cross-sectional study. BMC Musculoskelet. Disord., 20. · DOI
- Hofmann, 2015, Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women, Exp. Gerontol., 64, 35, 10.1016/j.exger.2015.02.008 · DOI
- Negaresh, 2019, Skeletal Muscle Hypertrophy, Insulin-like Growth Factor 1, Myostatin and Follistatin in Healthy and Sarcopenic Elderly Men: The Effect of Whole-body Resistance Training, Int. J. Prev. Med., 10, 29, 10.4103/ijpvm.IJPVM_310_17 · DOI
- Koyun, 2018, Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients, Saudi J. Kidney Dis. Transpl., 29, 809, 10.4103/1319-2442.239648 · DOI
- Carvalho, 2018, Myostatin and adipokines: The role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults, Cytokine, 107, 118, 10.1016/j.cyto.2017.12.008 · DOI
- Arrieta, 2019, Serum Myostatin Levels Are Higher in Fitter, More Active, and Non-Frail Long-Term Nursing Home Residents and Increase after a Physical Exercise Intervention, Gerontology, 65, 229, 10.1159/000494137 · DOI · Paper page
- Parnell, 2018, Activin subfamily peptides predict chronological age in humans, Physiol. Rep., 6, e13823, 10.14814/phy2.13823 · DOI
- Han, 2016, Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopenia, Sci. Rep., 6, 19457, 10.1038/srep19457 · DOI · Paper page
- Tay, 2015, Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults, Age (Dordr), 37, 121, 10.1007/s11357-015-9860-3 · DOI · Paper page
- Roh, 2019, Altered gene and protein expressions of vitamin D receptor in skeletal muscle in sarcopenic patients who sustained distal radius fractures, J. Bone Miner Metab., 37, 920, 10.1007/s00774-019-00995-0 · DOI
- Hedayati, 2016, Can the Serum Level of Myostatin be Considered as an Informative Factor for Cachexia Prevention in Patients with Medullary Thyroid Cancer?, Asian Pac. J. Cancer Prev., 17, 119, 10.7314/APJCP.2016.17.S3.119 · DOI
- Kim, 2019, Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors, J. Geriatr. Oncol., 10, 749, 10.1016/j.jgo.2019.03.015 · DOI
- Burch, 2017, Reduced serum myostatin concentrations associated with genetic muscle disease progression, J. Neurol., 264, 541, 10.1007/s00415-016-8379-6 · DOI
- Mariot, 2017, Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches, Nat. Commun., 8, 1859, 10.1038/s41467-017-01486-4 · DOI · Paper page
- Koch, 2020, Myostatin: A Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients, Mol. Ther. Methods Clin. Dev., 17, 1178, 10.1016/j.omtm.2020.04.022 · DOI
- Mariot, 2020, Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy, Mol. Ther. Methods Clin. Dev., 18, 415, 10.1016/j.omtm.2020.06.016 · DOI
- Vernerova, L., Horvathova, V., Kropackova, T., Vokurkova, M., Klein, M., Tomcik, M., Oreska, S., Spiritovic, M., Storkanova, H., and Hermankova, B. (2020). Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies. Rheumatology (Oxford). · DOI
- Lakshman, 2009, Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration, Mol. Cell Endocrinol., 302, 26, 10.1016/j.mce.2008.12.019 · DOI
- Wintgens, 2012, Plasma myostatin measured by a competitive ELISA using a highly specific antiserum, Clin. Chim. Acta, 413, 1288, 10.1016/j.cca.2012.04.023 · DOI
- Breitbart, A., Scharf, G.M., Duncker, D., Widera, C., Gottlieb, J., Vogel, A., Schmidt, S., Brandes, G., Heuft, H.G., and Lichtinghagen, R. (2013). Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients. PLoS ONE, 8. · DOI
- Cote, 2020, A Sensitive and Selective Immunoassay for the Quantitation of Serum Latent Myostatin after In Vivo Administration of SRK-015, a Selective Inhibitor of Myostatin Activation, SLAS Discov., 25, 95, 10.1177/2472555219860779 · DOI
- Zhang, 2019, A sensitive antibody-free 2D-LC-MS/MS assay for the quantitation of myostatin in the serum of different species, Bioanalysis, 11, 957, 10.4155/bio-2018-0311 · DOI
- Zhu, 2011, Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis, Am. J. Pathol., 179, 915, 10.1016/j.ajpath.2011.04.008 · DOI
- Saitoh, 2020, Discovery of a follistatin-derived myostatin inhibitory peptide, Bioorg. Med. Chem. Lett., 30, 126892, 10.1016/j.bmcl.2019.126892 · DOI
- Schafer, 2016, Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease, Cell Metab., 23, 1207, 10.1016/j.cmet.2016.05.023 · DOI · Paper page
- Chew, 2019, Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults, J. Nutr. Health Aging, 23, 979, 10.1007/s12603-019-1255-1 · DOI · Paper page
- Fife, E., Kostka, J., Kroc, L., Guligowska, A., Piglowska, M., Soltysik, B., Kaufman-Szymczyk, A., Fabianowska-Majewska, K., and Kostka, T. (2018). Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men. BMC Geriatr., 18. · DOI · Paper page
- Kalampouka, 2018, Differing Effects of Younger and Older Human Plasma on C2C12 Myocytes in Vitro, Front. Physiol., 9, 152, 10.3389/fphys.2018.00152 · DOI
- Yarasheski, 2002, Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting, J. Nutr. Health Aging, 6, 343
- Agergaard, 2015, Does vitamin-D intake during resistance training improve the skeletal muscle hypertrophic and strength response in young and elderly men?—A randomized controlled trial, Nutr. Metab. (Lond.), 12, 32, 10.1186/s12986-015-0029-y · DOI · Paper page
- Covington, 2016, Myokine Expression in Muscle and Myotubes in Response to Exercise Stimulation, Med. Sci. Sports Exerc., 48, 384, 10.1249/MSS.0000000000000787 · DOI · Paper page
- Hansson, 2019, Skeletal muscle signaling responses to resistance exercise of the elbow extensors are not compromised by a preceding bout of aerobic exercise, Am. J. Physiol. Regul. Integr. Comp. Physiol., 317, R83, 10.1152/ajpregu.00022.2019 · DOI
- Hinkley, 2017, Short-term intense exercise training reduces stress markers and alters the transcriptional response to exercise in skeletal muscle, Am. J. Physiol. Regul. Integr. Comp. Physiol., 312, R426, 10.1152/ajpregu.00356.2016 · DOI
- Ross, 2019, Skeletal Muscle mRNA Response to Hypobaric and Normobaric Hypoxia After Normoxic Endurance Exercise, High Alt. Med. Biol., 20, 141, 10.1089/ham.2018.0147 · DOI
- Schwarz, 2016, Effect of resistance exercise intensity on the expression of PGC-1alpha isoforms and the anabolic and catabolic signaling mediators, IGF-1 and myostatin, in human skeletal muscle, Appl. Physiol. Nutr. Metab., 41, 856, 10.1139/apnm-2016-0047 · DOI
- Silvennoinen, 2015, PGC-1 isoforms and their target genes are expressed differently in human skeletal muscle following resistance and endurance exercise, Physiol. Rep., 3, e12563, 10.14814/phy2.12563 · DOI · Paper page
- Watson, 2017, The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease, Front. Physiol., 8, 541, 10.3389/fphys.2017.00541 · DOI
- Shad, 2019, One Week of Step Reduction Lowers Myofibrillar Protein Synthesis Rates in Young Men, Med. Sci. Sports Exerc., 51, 2125, 10.1249/MSS.0000000000002034 · DOI
- Han, D.S., Hsiao, M.Y., Wang, T.G., Chen, S.Y., and Yang, W.S. (2016). Association of serum myokines and aerobic exercise training in patients with spinal cord injury: An observational study. BMC Neurol., 16. · DOI
- He, 2018, Myokine Response to High-Intensity Interval vs. Resistance Exercise: An Individual Approach, Front. Physiol., 9, 1735, 10.3389/fphys.2018.01735 · DOI · Paper page
- Kabak, B., Belviranli, M., and Okudan, N. (2018). Irisin and myostatin responses to acute high-intensity interval exercise in humans. Horm. Mol. Biol. Clin. Investig., 35. · DOI
- Kerschan-Schindl, K., Thalmann, M.M., Weiss, E., Tsironi, M., Foger-Samwald, U., Meinhart, J., Skenderi, K., and Pietschmann, P. (2015). Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race. PLoS ONE, 10. · DOI · Paper page
- Paoli, 2015, Protein supplementation increases postexercise plasma myostatin concentration after 8 weeks of resistance training in young physically active subjects, J. Med. Food, 18, 137, 10.1089/jmf.2014.0004 · DOI · Paper page
- Farhani, 2019, Blood Flow Restriction During Futsal Training Increases Muscle Activation and Strength, Front. Physiol., 10, 614, 10.3389/fphys.2019.00614 · DOI
- Bagheri, 2019, Effects of upper-body, lower-body, or combined resistance training on the ratio of follistatin and myostatin in middle-aged men, Eur. J. Appl. Physiol., 119, 1921, 10.1007/s00421-019-04180-z · DOI
- Mafi, 2019, Improvement in Skeletal Muscle Strength and Plasma Levels of Follistatin and Myostatin Induced by an 8-Week Resistance Training and Epicatechin Supplementation in Sarcopenic Older Adults, J. Aging Phys. Act., 27, 384, 10.1123/japa.2017-0389 · DOI · Paper page
- Micielska, 2019, The beneficial effects of 15 units of high-intensity circuit training in women is modified by age, baseline insulin resistance and physical capacity, Diabetes Res. Clin. Pract., 152, 156, 10.1016/j.diabres.2019.05.009 · DOI · Paper page
- Wu, 2019, Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa, Clin. Endocrinol. (Oxf.), 90, 88, 10.1111/cen.13871 · DOI
- Tsioga, 2015, Plasma myostatin is only a weak predictor for weight maintenance in obese adults, Exp. Clin. Endocrinol. Diabetes, 123, 466, 10.1055/s-0035-1559663 · DOI
- Assyov, 2017, Myostatin and carbohydrate disturbances, Endocr. Res., 42, 102, 10.1080/07435800.2016.1198802 · DOI
- Tanaka, 2018, Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients, Diabetes Res. Clin. Pract., 142, 195, 10.1016/j.diabres.2018.05.041 · DOI
- 2016, Relationship between myostatin and irisin in type 2 diabetes mellitus: A compensatory mechanism to an unfavourable metabolic state?, Endocrine, 52, 54, 10.1007/s12020-015-0758-8 · DOI
- Zhao, 2018, Early second trimester maternal serum markers in the prediction of gestational diabetes mellitus, J. Diabetes Investig., 9, 967, 10.1111/jdi.12798 · DOI
- Li, 2016, Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis, Endocrinology, 157, 282, 10.1210/en.2015-1546 · DOI
- Kong, 2018, Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin, Cell Metab., 28, 631, 10.1016/j.cmet.2018.07.004 · DOI · Paper page
- Steculorum, 2016, AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue, Cell, 165, 125, 10.1016/j.cell.2016.02.044 · DOI · Paper page
- Consitt, 2018, The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials, J. Frailty Aging, 7, 21
- Akerfeldt, 2015, Postsurgical Acute Phase Reaction is Associated with Decreased Levels of Circulating Myostatin, Inflammation, 38, 1727, 10.1007/s10753-015-0149-6 · DOI
- Wallner, 2019, Myostatin serum concentration as an indicator for deviated muscle metabolism in severe burn injuries, Scand. J. Surg., 108, 297, 10.1177/1457496918812230 · DOI
- Zhao, C., Shao, Y., Lin, C., Zeng, C., Fang, H., Pan, J., and Cai, D. (2017). Myostatin serum concentrations are correlated with the severity of knee osteoarthritis. J. Clin. Lab. Anal., 31. · DOI
- Su, 2019, Myostatin induces tumor necrosis factor-alpha expression in rheumatoid arthritis synovial fibroblasts through the PI3K-Akt signaling pathway, J. Cell. Physiol., 234, 9793, 10.1002/jcp.27665 · DOI
- Ebenbichler, 2019, Rheumatoid arthritis in remission: Decreased myostatin and increased serum levels of periostin, Wien. Klin. Wochenschr., 131, 1, 10.1007/s00508-018-1386-0 · DOI
- Anker, 1997, Wasting as independent risk factor for mortality in chronic heart failure, Lancet, 349, 1050, 10.1016/S0140-6736(96)07015-8 · DOI · Paper page
- Gruson, 2011, Increased plasma myostatin in heart failure, Eur. J. Heart Fail., 13, 734, 10.1093/eurjhf/hfr024 · DOI
- Ishida, 2017, Myostatin signaling is up-regulated in female patients with advanced heart failure, Int. J. Cardiol., 238, 37, 10.1016/j.ijcard.2017.03.153 · DOI
- Chen, 2019, Predictive value of serum myostatin for the severity and clinical outcome of heart failure, Eur. J. Intern. Med., 64, 33, 10.1016/j.ejim.2019.04.017 · DOI
- Meloux, A., Rochette, L., Maza, M., Bichat, F., Tribouillard, L., Cottin, Y., Zeller, M., and Vergely, C. (2019). Growth Differentiation Factor-8 (GDF8)/Myostatin is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial Infarction. J. Clin. Med., 9. · DOI
- Han, 2017, Relation between serum myokines and phase II cardiac rehabilitation, Medicine (Baltimore), 96, e6579, 10.1097/MD.0000000000006579 · DOI
- Baan, 2015, Myostatin and IGF-I signaling in end-stage human heart failure: A qRT-PCR study, J. Transl. Med., 13, 1, 10.1186/s12967-014-0365-0 · DOI
- Castillero, 2018, Structural and functional cardiac profile after prolonged duration of mechanical unloading: Potential implications for myocardial recovery, Am. J. Physiol. Heart Circ. Physiol., 315, H1463, 10.1152/ajpheart.00187.2018 · DOI
- Antunez, 2015, Myostatin and insulin-like growth factor-1 in hypertensive heart disease: A prospective study in human heart donors, J. Hypertens., 33, 851, 10.1097/HJH.0000000000000493 · DOI
- Fernlund, 2017, Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young, Pediatr. Cardiol., 38, 853, 10.1007/s00246-017-1593-x · DOI
- Ju, C.R., Chen, M., Zhang, J.H., Lin, Z.Y., and Chen, R.C. (2016). Higher Plasma Myostatin Levels in Cor Pulmonale Secondary to Chronic Obstructive Pulmonary Disease. PLoS ONE, 11. · DOI
- Ju, 2017, Plasma myostatin levels are related to the extent of right ventricular dysfunction in exacerbation of chronic obstructive pulmonary disease, Biomarkers, 22, 246, 10.1080/1354750X.2016.1203999 · DOI
- Zhang, 2018, Correlation between peripheral skeletal muscle functions and the stable phase of COPD in older patients, Eur. Rev. Med. Pharmacol. Sci., 22, 5317
- Qi, 2019, MSTN Attenuates Cardiac Hypertrophy through Inhibition of Excessive Cardiac Autophagy by Blocking AMPK /mTOR and miR-128/PPARgamma/NF-kappaB, Mol. Ther. Nucleic Acids, 19, 507, 10.1016/j.omtn.2019.12.003 · DOI
- Biesemann, 2015, Myostatin induces interstitial fibrosis in the heart via TAK1 and p38, Cell Tissue Res., 361, 779, 10.1007/s00441-015-2139-2 · DOI
- Yano, S., Nagai, A., Isomura, M., Yamasaki, M., Kijima, T., Takeda, M., Hamano, T., and Nabika, T. (2015). Relationship between Blood Myostatin Levels and Kidney Function:Shimane CoHRE Study. PLoS ONE, 10. · DOI
- Raptis, 2018, Serum Fas Ligand, Serum Myostatin and Urine TGF-beta1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function, Kidney Blood Press. Res., 43, 744, 10.1159/000489911 · doi:10.1159/000489911
- Esposito, 2017, Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities, BioMed Res. Int., 2017, 7635459, 10.1155/2017/7635459 · DOI
- Esposito, P., Battaglia, Y., La Porta, E., Grignano, M.A., Caramella, E., Avella, A., Peressini, S., Sessa, N., Albertini, R., and Di Natali, G. (2019). Significance of serum Myostatin in hemodialysis patients. BMC Nephrol., 20. · DOI
- Wang, 2015, Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney Disease, Oxid. Med. Cell. Longev., 2015, 684965, 10.1155/2015/684965 · DOI
- Carrarelli, 2015, Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis, Fertil. Steril., 104, 744, 10.1016/j.fertnstert.2015.05.032 · DOI
- Carrarelli, 2017, Deep Infiltrating Endometriosis and Endometrial Adenocarcinoma Express High Levels of Myostatin and Its Receptors Messenger RNAs, Reprod. Sci., 24, 1577, 10.1177/1933719117698579 · DOI
- Peiris, 2015, Expression of Myostatin in Intrauterine Growth Restriction and Preeclampsia Complicated Pregnancies and Alterations to Cytokine Production by First-Trimester Placental Explants Following Myostatin Treatment, Reprod. Sci., 22, 1202, 10.1177/1933719115572482 · DOI
- Tsigkou, 2015, Expression Levels of Myostatin and Matrix Metalloproteinase 14 mRNAs in Uterine Leiomyoma are Correlated With Dysmenorrhea, Reprod. Sci., 22, 1597, 10.1177/1933719115592710 · DOI
- Trappe, 2013, Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults, Am. J. Physiol. Regul. Integr. Comp. Physiol., 304, R198, 10.1152/ajpregu.00245.2012 · DOI · Paper page
- Patel, 2018, Prior acetaminophen consumption impacts the early adaptive cellular response of human skeletal muscle to resistance exercise, J. Appl. Physiol. (1985), 124, 1012, 10.1152/japplphysiol.00922.2017 · DOI
- Heisterberg, 2018, Effect of Losartan on the Acute Response of Human Elderly Skeletal Muscle to Exercise, Med. Sci. Sports Exerc., 50, 225, 10.1249/MSS.0000000000001438 · DOI
- Schakman, 2009, Mechanisms of muscle atrophy induced by glucocorticoids, Horm. Res., 72, 36
- Wang, R., Jiao, H., Zhao, J., Wang, X., and Lin, H. (2016). Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage. PLoS ONE, 11. · DOI
- Macedo, 2016, Time-course changes of catabolic proteins following muscle atrophy induced by dexamethasone, Steroids, 107, 30, 10.1016/j.steroids.2015.12.016 · DOI
- Dhindsa, 2019, Acute effects of insulin on skeletal muscle growth and differentiation genes in men with type 2 diabetes, Eur. J. Endocrinol., 181, K55, 10.1530/EJE-19-0514 · DOI
- Hong, 2019, Long-term insulin treatment leads to a change in myosin heavy chain fiber distribution in OLETF rat skeletal muscle, J. Cell. Biochem., 120, 2404, 10.1002/jcb.27571 · DOI
- Yamakage, 2020, Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial, J. Diabetes Investig., 11, 653, 10.1111/jdi.13179 · DOI
Cited by
Metabolic Syndrome and Sarcopenia
Nishikawa, H., Asai, A., Fukunishi, S., Nishiguchi, S., & Higuchi, K. (2021) · Nutrients · doi:10.3390/nu13103519 · Cited by 321
Exercise therapy for people with sarcopenic obesity: myokines and adipokines as effective actors
Alizadeh Pahlavani, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.811751 · Cited by 145
“Myostatin is found in large amounts in skeletal muscle (39).”
BackgroundInfluentialStefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
Baig, M. H., Ahmad, K., Moon, J. S., Park, S.-Y., Ho Lim, J., Chun, H. J., Qadri, A. F., Hwang, Y. C., Jan, A. T., Ahmad, S. S., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.876078 · Cited by 135
Baumgartner, M., Lischka, J., Schanzer, A., de Gier, C., Walleczek, N.-K., Greber-Platzer, S., & Zeyda, M. (2022) · Nutrients · doi:10.3390/nu14102133 · Cited by 9
Metadata
- Authors
- Baczek, J., Silkiewicz, M., & Wojszel, Z. B.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-08-11
- Volume
- 12
- Issue
- 8
- Pages
- 2401
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W3048382626
- Cited by
- 156
- References
- 41
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Uniwersytet Medyczny w Białymstoku (SUB/1/DN/20/005/3301)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.